Skip to main content
Fig. 1 | Journal of Nanobiotechnology

Fig. 1

From: Functionalized nanoparticles with monocyte membranes and rapamycin achieve synergistic chemoimmunotherapy for reperfusion-induced injury in ischemic stroke

Fig. 1

Characterization of the McM/RNPs. a The sizes and b zeta potentials of McM, RNPs and McM/RNPs (n = 3, mean ± SD). c Drug loading efficiency (LE) and encapsulating efficiency (EE) of RNPs. d TEM images of RNPs and McM/RNPs (scale bar = 100 nm). e Western blotting results of integrin α4 (150 kDa /140 kDa), integrin β1 (135 kDa), CD 47 (35 kDa) and β-actin (42 kDa). f Proteins in cell lysis, McM, McM/RNPs, and RNPs by SDS-PAGE. Coomassie brilliant blue staining was used to detect the protein content. g In vitro release profiles of RNPs and McM/RNPs (n = 6)

Back to article page